It has been recently demonstrated that ovarian cancers with inactivating mutations of CDK12 present genomic instability characterized by hundreds of tandem duplications of up to ten megabases (MB) in size (CDK12 TD-plus phenotype) (17). This evidence concerns the gene CDK12 and ovarian carcinoma.